6
Tetrahedron
ACCEPTED MANUSCRIPT
1H), 1.54 – 1.40 (m, 3H), 1.40 – 1.16 (m, 5H), 0.92 (td, J = 7.2,
provided 58.0 mg (51% yield, >20:1 dr, >20:1 E/Z) of the title
3.4 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 188.2, 168.8,
138.2, 129.0, 128.7, 127.2, 118.7, 47.6, 38.7, 34.6, 32.9, 32.2,
30.1, 21.4, 20.8, 14.3, 14.3. HRMS (EI): Calcd for C19H26O1S1
compound as a yellow oil. IR (film): 2942 (m), 2864 (m), 1674
(m), 1641 (m), 1495 (w), 1463 (w), 1389 (w), 1276 (m), 1261
(m), 1113 (m), 1035 (m), 882 (w), 764 (s), 750 (s), 700 (w) cm-1.
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.27 (m, 4H), 7.25 – 7.21
(m, 1H), 5.98 – 5.92 (m, 1H), 4.16 (s, 2H), 3.74 – 3.66 (m, 2H),
3.44 – 3.33 (m, 1H), 3.26 (dddd, J = 19.4, 9.0, 2.4 Hz, 1H), 2.99
– 2.86 (m, 1H), 2.68 (dddd, J = 19.4, 4.3, 2.5 Hz, 1H), 2.48 –
2.33 (m, 1H), 1.76 (ddd, J = 25.0, 12.7, 5.9 Hz, 2H), 1.56 – 1.39
(m, 2H), 1.10 – 1.00 (m, 21H). 13C NMR (125 MHz, CDCl3) δ
188.1, 169.4, 138.2, 129.0, 128.7, 127.2, 120.2, 66.4, 49.1, 41.4,
38.7, 36.4, 36.3, 35.8, 32.9, 18.2, 12.1. HRMS (EI): Calcd for
C26H40O2S1Si1 [M]+: 444.2513, Found: 444.2522. Optical
Rotation: [α]D20 +15.9 (c = 1.00, CHCl3) for an enantiomerically
enriched sample of 94:6 er. The enantiomeric purity was
established by HPLC analysis using a chiral column (Lux 3u
[M]+: 302.1699, Found: 302.1696. Optical Rotation: [α]D -7.7
20
(c = 1.00, CHCl3) for an enantiomerically enriched sample of
93:7 er. The enantiomeric purity was established by HPLC
analysis using a chiral column (Lux 3u Cellulose-1 column, 22
°C, 0.25 mL/min, 99:1 hexanes:isopropanol, 254 nm, tminor
24.454 min, tmajor = 31.649 min). See supporting information part
B for HPLC chromatograms.
=
S-benzyl
(E)-2-((2S,3R)-3-isopropyl-2-
methylcyclobutylidene)ethanethioate [22]: Prepared according
to the general procedure utilizing cis-4-methyl-2-pentene as the
alkene component. Purification by silica gel chromatography
(hexanes – 2% EtOAc:hexanes gradient) provided 40.1 mg (58%
yield, 5:1 E/Z, 10:1 rr) of the title compound as an inseparable
mixture of isomers. IR (film): 3062 (w), 3029 (w), 2957 (m),
2929 (m), 2870 (w), 1674 (s), 1634 (s), 1454 (m), 1416 (w), 1335
Cellulose-1
column,
22
°C,
0.5
mL/min,
99:1
hexanes:isopropanol, 254 nm, tminor = 10.348 min, tmajor = 10.822
min). See supporting information part
chromatograms.
B
for HPLC
(w), 1160 (w), 1038 (s), 827 (m), 751 (w), 700 (m) cm-1. H
1
NMR (500 MHz, CDCl3) δ 7.40 – 7.18 (m, 5H), 6.18 – 6.08 (m,
1H), 4.18 (s, 2H), 3.16 (ddd, J = 17.4, 8.3, 2.4 Hz, 1H), 2.77 –
2.70 (m, 1H), 2.69 – 2.54 (m, 2H), 1.95 – 1.82 (m, 1H), 1.12 (d, J
= 6.8 Hz, 3H), 1.05 – 0.98 (m, 3H), 0.91 (d, J = 6.4 Hz, 3H).13C
NMR (125 MHz, CDCl3) δ 188.2, 167.5, 138.2, 129.0, 129.0,
129.0, 128.7, 127.2, 119.4, 55.5, 40.3, 33.0, 29.3, 27.3, 21.8,
21.6, 16.0.HRMS (EI): Calcd for C17H22O1S1 [M]+: 274.1386,
S-(4-chlorobenzyl)
dimethylbicyclo[6.2.0]decan-9-ylidene)ethanethioate
2-((1R,8S)-10,10-
[35]:
HNTf2 (14.0 mg, 0.05 mmol, 0.20 equiv) was added to a flame
dried round bottom flask in an argon filled glovebox, capped
with a septum, and removed from the glovebox. CH2Cl2 (0.50
mL, 0.50 M) was added and the reaction mixture was cooled to -
78 oC. Oxazaborolidine 3 (0.25 M in PhMe, 250 µL, 0.06 mmol,
0.25 equiv) was added and allowed to stir for 30 minutes.
Cyclooctene (160 µL, 1.25 mmol, 5.00 equiv) was added,
followed quickly by S-(4-chlorobenzyl) 4-methylpenta-2,3-
dienethioate 32 (63.0 mg, 0.25 mmol, 1.00 equiv) and the
reaction was allowed to warm to room temperature. After 16
hours, the reaction was quenched with 100 µL Et3N and the
solution was concentrated. Purification by silica gel
chromatography (hexanes – 2% Et2O:hexanes gradient) provided
82.4 mg (93% yield, ~1:1 E/Z mixture of alkene isomers) of the
title compound as a pale yellow oil. For characterization, small
amounts of the respective E-isomer were separated. E-isomer:
IR (film): 2918 (br, m), 2850 (m), 1672 (s), 1636 (s), 1490 (m),
1460 (w), 1443 (w), 1339 (w), 1261 (w), 1242 (w), 1092 (m),
1066 (s), 1066 (s), 980 (w), 813 (s), 738 (m), 678 (w), 641 (w),
552 (w), 509 (w cm-1. 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.11
(m, 4H), 5.87 – 5.77 (m, 1H), 4.07 (d, J = 14.5 Hz, 1H), 4.01 (d,
J = 13.4 Hz, 1H), 3.27 (t, J = 10.0 Hz, 1H), 2.07 – 1.92 (m, 2H),
1.76 – 1.41 (m, 6H), 1.42 – 1.33 (m, 1H), 1.31 – 1.08 (m, 4H),
1.04 (s, 3H), 1.00 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 187.3,
179.8, 137.0, 133.0, 130.3, 128.8, 116.6, 48.4, 46.13, 45.4, 32.3,
31.21, 29.2, 28.1, 27.9, 26.1, 25.7, 22.5, 22.1. HRMS (ESI):
Calcd for C21H27O1Cl1S1Na1 [M+Na]+: 385.1369, Found:
385.1369. The enantiomeric purity was established by HPLC
analysis using a chiral column. E-isomer: (Lux 3u Cellulose-2
column, 22 °C, 0.25 mL/min, 400:1 hexanes:isopropanol, 254
nm, tminor = 30.711 min, tmajor = 34.576 min): 96:4 er. Z-isomer:
(Lux 3u Cellulose-2 0.25mL/min, 400:1 hexanes:isopropanol,
254 nm, tmajor = 36.894 min, tminor = 41.498 min): 86:14 er.
Absolute stereochemistry only tentatively assigned. See
supporting information part B for HPLC chromatograms.
20
Found: 274.1384. Optical Rotation: [α]D -26.7 (c = 1.00,
CHCl3) for an enantiomerically enriched sample of 94:6 er. The
enantiomeric purity was established by HPLC analysis using a
chiral column (Lux 3u Cellulose-1 column, 22 °C, 0.25 mL/min,
400:1 hexanes:isopropanol, 254 nm, tminor = 38.095 min, tmajor
=
56.180 min). See supporting information part B for HPLC
chromatograms.
S-Benzyl
(S,Z)-2-(3,3-dimethyl-2-(2-
((triisopropylsilyl)oxy)ethyl)cyclobutylidene)ethanethioate
[26]: Prepared according to the general procedure utilizing
triisopropyl((4-methylpent-3-en-1-yl)oxy)silane as the alkene
component. Purification by silica gel chromatography (hexanes –
2% Et2O:hexanes gradient) provided 78.0 mg (70% yield, 1:1
Z/E, mixture of alkene isomers) of the title compound as a
colorless oil. For characterization, small amounts of the
respective isomers were separated. Z-isomer: IR (film): 2942
(s), 2865 (s), 1738 (m) 1678 (s), 1647 (m), 1071 (m), 1033 (m),
883 (m), 682 (m) cm-1 1H NMR (600 MHz, CDCl3) δ 7.36 – 7.19
(m, 5H), 5.98 (q, J = 2.1 Hz, 1H), 4.14 (s, 2H), 3.84 – 3.72 (m,
1H), 3.72 – 3.64 (m, 1H), 3.01 (ddt, J = 8.5, 5.6, 2.8 Hz, 1H),
2.57 – 2.51 (m, 1H), 2.35 (ddd, J = 16.3, 3.0, 1.7 Hz, 1H), 2.21 –
2.06 (m, 1H), 1.88 – 1.78 (m, 1H), 1.19 (s, 3H), 1.13 (s, 3H),
1.08 (d, J = 5.3 Hz, 21H). 13C NMR (125 MHz, CDCl3) δ 187.0,
164.7, 138.2, 129.0, 128.7, 127.2, 120.7, 62.8, 52.4, 44.6, 35.3,
33.1, 32.5, 29.9, 23.9, 18.2, 12.2. HRMS (APCI): Calcd for
C26H43O2S1Si1 [M]+: 447.2748, Found: 447.2747. Optical
20
Rotation: [α]D +1.6 (c = 0.64, CHCl3) for an enantiomerically
enriched sample of 87:13 er. The enantiomeric purity was
established by HPLC analysis of the respective deprotected
bicyclic thioester, see the supporting information part A for
details.
The reaction was repeated using oxazaborolidine 34 under
otherwise unchanged conditions. The isolated yield was 84.2 mg
(95% yield, ~4:1 E/Z) and the corresponding er was 98:2 for the
major E-isomer and 81:19 for the minor Z-isomer. Absolute
stereochemistry only tentatively assigned. See supporting
information part B for HPLC chromatograms.
S-benzyl
(E)-2-((1S,3R,5S)-3-
(((triisopropylsilyl)oxy)methyl)bicyclo[3.2.0]heptan-6-
ylidene)ethanethioate [28]: Prepared according to the general
procedure
utilizing
(cyclopent-3-en-1-
ylmethoxy)triisopropylsilane as the alkene component.
Purification by silica gel chromatography (2% EtOAc:hexanes)
S-(4-chlorobenzyl)
dimethylbicyclo[3.2.0]heptan-6-ylidene)ethanethioate
2-((1R,5S)-7,7-
[36]: